Skip to search formSkip to main contentSkip to account menu

Squamous Cell Carcinoma Antigen Measurement

Known as: SCCAG, Serpin B3 Measurement, Squamous Cell Carcinoma Antigen 
The determination of the squamous cell carcinoma antigen present in a sample.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
It is desirable to have a biomarker which can facilitate low‐dose CT in diagnosis of early stage lung cancer. CTAPIII/CXCL7 is… 
2016
2016
BackgroundThe Glasgow Prognostic Score (GPS) is an established inflammation-based system that is used to predict the prognosis… 
2016
2016
PurposeThis study aimed to identify the surgical-pathologic risk factors of lymph node metastasis (LNM) in patients with early… 
2007
2007
Background:  We present our initial experience with the use of the squamous cell carcinoma (SCC) antigen (SCCAg) in 16 men with… 
Review
2007
Review
2007
ZusammenfassungGrundlagen: Eine exakte Tumorklassifikation ist sowohl für die Wahl des Behandlungsverfahrens im Rahmen einer… 
2003
2003
To evaluate whether serum squamous cell carcinoma antigen (SCCAg) measurements may be of use in identifying nodal metastases in… 
Review
1996
Review
1996
  • H. Kato
  • Anticancer research
  • 1996
  • Corpus ID: 45244332
Squamous cell carcinoma antigen (SCCA) has been used as a promising aid for the management of squamous cell carcinoma of various… 
1992
1992
An ideal tumor marker should be sensitive in tumor-bearing patients while having adequate specificity so that controls do not…